Lv48
490 积分 2025-12-07 加入
Product-Intrinsic NF-κB-Driven Transcriptional Programs Connote Durability of CAR-T Response in Multiple Myeloma
1个月前
已关闭
Novel therapies for refractory idiopathic inflammatory myopathy-associated interstitial lung disease
1个月前
已完结
Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in Multiple Myeloma: 30 Years in the Making
1个月前
已完结
In vivo CAR-T for solid tumors: facing all the challenges of ex vivo CAR-T and more
1个月前
已完结
CART-Cell Therapy in Pediatric Acute Lymphoblastic Leukemia: A Review for General Pediatricians
1个月前
已完结
Chimeric Antigen Receptor T Cell Targeting of Natural Killer Cells in Peripheral Blood and Tissues of Rhesus Macaques
1个月前
已完结
Collapsing Glomerulopathy and Thrombotic Microangiopathy after Chimeric Antigen Receptor T Cell Therapy
1个月前
已关闭
Integrating Palliative Care into Relapsed/Refractory Multiple Myeloma in the Immunotherapy Era: A Narrative Review
1个月前
已完结
The Modular CAR: Adapting T Cells without Reengineering Them
2个月前
已完结
Chimeric HLA Antibody Receptor (CHAR) T Cells to Specifically Eliminate HLA-DQ–Specific B Cells
2个月前
已完结
皖公网安备34019202002308
